Pembrolizumab: living up to expectations

被引：5

作者：

Ansell, Stephen M. ^{[1
]}

机构：

[1] Mayo Clin, Rochester, MN 55905 USA

来源：

BLOOD | 2019年 / 134卷 / 14期

关键词：

HODGKIN LYMPHOMA; PHASE-II; NIVOLUMAB; BLOCKADE;

D O I：

10.1182/blood.2019002417

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

Blocking programmed death 1 (PD-1) signaling in relapsed Hodgkin lymphoma results in high response rates,(1-3) and Chen et al, in this issue of Blood, report the outcome of patients treated with pembrolizumab with 2 years of follow-up.(4) They confirm that responses in patients treated with this PD-1-blocking antibody are durable and find that patients continue to tolerate PD-1 blockade well with extended treatment.

引用

页码：1114 / 1115

页数：4

共 7 条

[1]

PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma [J].

Ansell, Stephen M. ;

Lesokhin, Alexander M. ;

Borrello, Ivan ;

Halwani, Ahmad ;

Scott, Emma C. ;

Gutierrez, Martin ;

Schuster, Stephen J. ;

Millenson, Michael M. ;

Cattry, Deepika ;

Freeman, Gordon J. ;

Rodig, Scott J. ;

Chapuy, Bjoern ;

Ligon, Azra H. ;

Zhu, Lili ;

Grosso, Joseph F. ;

Kim, Su Young ;

Timmerman, John M. ;

Shipp, Margaret A. ;

Armand, Philippe .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (04) :311-319

[2]

Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial [J].

Armand, Philippe ;

Engert, Andreas ;

Younes, Anas ;

Fanale, Michelle ;

Santoro, Armando ;

Zinzani, Pier Luigi ;

Timmerman, John M. ;

Collins, Graham P. ;

Ramchandren, Radhakrishnan ;

Cohen, Jonathon B. ;

De Boer, Jan Paul ;

Kuruvilla, John ;

Savage, Kerry J. ;

Trneny, Marek ;

Shipp, Margaret A. ;

Kato, Kazunobu ;

Sumbul, Anne ;

Farsaci, Benedetto ;

Ansell, Stephen M. .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (14) :1428-+

[3]

Mass cytometry of Hodgkin lymphoma reveals a CD4+ regulatory T-cell-rich and exhausted T-effector microenvironment [J].

Cader, Fathima Zumla ;

Schackmann, Ron C. J. ;

Hu, Xihao ;

Wienand, Kirsty ;

Redd, Robert ;

Chapuy, Bjoern ;

Ouyang, Jing ;

Paul, Nicole ;

Gjini, Evisa ;

Lipschitz, Mikel ;

Armand, Philippe ;

Wu, David ;

Fromm, Jonathan R. ;

Neuberg, Donna ;

Liu, X. Shirley ;

Rodig, Scott J. ;

Shipp, Margaret A. .

BLOOD, 2018, 132 (08) :825-836

[4]

Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087 [J].

Chen, Robert ;

Zinzani, Pier Luigi ;

Lee, Hun Ju ;

Armand, Philippe ;

Johnson, Nathalie A. ;

Brice, Pauline ;

Radford, John ;

Ribrag, Vincent ;

Molin, Daniel ;

Vassilakopoulos, Theodoros P. ;

Tomita, Akihiro ;

von Tresckow, Bastian ;

Shipp, Margaret A. ;

Lin, Jianxin ;

Kim, Eunhee ;

Nahar, Akash ;

Balakumaran, Arun ;

Moskowitz, Craig H. .

BLOOD, 2019, 134 (14) :1144-1153

[5]

Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma [J].

Chen, Robert ;

Zinzani, Pier Luigi ;

Fanale, Michelle A. ;

Armand, Philippe ;

Johnson, Nathalie A. ;

Brice, Pauline ;

Radford, John ;

Ribrag, Vincent ;

Molin, Daniel ;

Vassilakopoulos, Theodoros P. ;

Tomita, Akihiro ;

von Tresckow, Bastian ;

Shipp, Margaret A. ;

Zhang, Yinghua ;

Ricart, Alejandro D. ;

Balakumaran, Arun ;

Moskowitz, Craig H. .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (19) :2125-+

[6]

Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma [J].

Roemer, Margaretha G. M. ;

Redd, Robert A. ;

Cader, Fathima Zumla ;

Pak, Christine J. ;

Abdelrahman, Sara ;

Ouyang, Jing ;

Sasse, Stephanie ;

Younes, Anas ;

Fanale, Michelle ;

Santoro, Armando ;

Zinzani, Pier Luigi ;

Timmerman, John ;

Collins, Graham P. ;

Ramchandren, Radhakrishnan ;

Cohen, Jonathon B. ;

De Boer, Jan Paul ;

Kuruvilla, John ;

Savage, Kerry J. ;

Trneny, Marek ;

Ansell, Stephen ;

Kato, Kazunobu ;

Farsaci, Benedetto ;

Sumbul, Anne ;

Armand, Philippe ;

Neuberg, Donna S. ;

Pinkus, Geraldine S. ;

Ligon, Azra H. ;

Rodig, Scott J. ;

Shipp, Margaret A. .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (10) :942-+

[7]

PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome [J].

Roemer, Margaretha G. M. ;

Advani, Ranjana H. ;

Ligon, Azra H. ;

Natkunam, Yasodha ;

Redd, Robert A. ;

Homer, Heather ;

Connelly, Courtney F. ;

Sun, Heather H. ;

Daadi, Sarah E. ;

Freeman, Gordon J. ;

Armand, Philippe ;

Chapuy, Bjoern ;

de Jong, Daphne ;

Hoppe, Richard T. ;

Neuberg, Donna S. ;

Rodig, Scott J. ;

Shipp, Margaret A. .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (23) :2690-+

← 1 →